Inappropriate IFN responses, either caused by autoantibodies against IFNs or by inborn genetic errors, were detected in a substantial selection of patients with life-threatening COVID-19, whereas these errors are rare in the general population. The gene discussed is IFNA1; the disease is COVID-19.